PAPER Kapoor A, Dutt S, Nguyen A, Lohman T, Gaubert A, Alitin JP, Sible IJ, Marshall A, Shenasa F, Engstrom AC, Bradford DR, Rodgers K, Nation DA
SEARCH RESULTS
482 RESULTS
PAPER Lee CY, Wang WF, Hsu JL, Yang YH, Jhang KM
A 52-week, open-label, observational study evaluating tolerability, efficacy and physicians satisfaction of rivastigmine oral solution in Alzheimer's disease in Taiwan.
J Alzheimers Dis Rep. 2025;9:25424823241311860. Epub 2025 Jan 15 PubMed.PAPER Sejourne C, Barker MS, Heath MR, Gazes Y, Fremont R, Perez YG, Hearne LJ, Wassermann EM, Tierney MC, Manoochehri M, Huey ED, Grafman J
Neuropsychiatric and behavioral symptom clusters in frontotemporal dementia.
J Alzheimers Dis Rep. 2025;9:25424823251324391. Epub 2025 Mar 2 PubMed.PAPER Ahn H, Joung H, Byun MS, Park JE, Jung G, Yi D, Lee DY
Normative data for the CERAD verbal episodic memory tests in a sample of older illiterate Korean women.
J Alzheimers Dis Rep. 2025;9:25424823251321750. Epub 2025 Feb 27 PubMed.PAPER Sun F, Wang QX, Zhao LP, Jin Q, Jin SH, Xu JT, Yin MJ, Jin C, Wang JH
Sex-specific effects of dietary salt intake on circulating Alzheimer's disease-related biomarkers in aged rats.
J Alzheimers Dis Rep. 2025;9:25424823251315388. Epub 2025 Jan 31 PubMed.PAPER Chaudhuri I, Das S
Heterogeneous treatment effects of BCG vaccine on Alzheimer's disease risk.
J Alzheimers Dis Rep. 2025;9:25424823251317955. Epub 2025 Jan 31 PubMed.PAPER Cottrill R, Ekanayake A, Grove C, Peiris S, Corbett N, Ahmed B, Jens W, Brearly T, Kanekar S, Eslinger P, Yang Q, Karunanayaka P
Alzheimer's disease (AD) in multiple sclerosis (MS): A systematic review of published cases, mechanistic links between AD and MS, and possible clinical evaluation of AD in MS.
J Alzheimers Dis Rep. 2025;9:25424823251316134. Epub 2025 Jan 31 PubMed.PAPER Saeed A, Chang Y, Swanson J, Vu M, Mapstone M, Villemagne VL, Snitz BE, Royse SK, Wang H, Lopresti B, Aizenstein HJ, Wu M, Kip K, Reis SE, Lopez O, Cohen A
Association of mid-life cardiovascular risk with biomarkers of Alzheimer's disease, neurodegeneration, and white matter hyperintensities: Heart SCORE brain study.
J Alzheimers Dis Rep. 2025;9:25424823241299297. Epub 2025 Jan 15 PubMed.PAPER Lathe R, Balin B
A historic case of relapsing-remitting Alzheimer's disease in an adolescent attributed to scarlet fever.
J Alzheimers Dis Rep. 2025;9:25424823241298530. Epub 2025 Jan 14 PubMed.PAPER Grant WB
How follow-up period in prospective cohort studies affects the relationship between baseline fish consumption and risk of Alzheimer's disease and dementia.
J Alzheimers Dis Rep. 2025;9:25424823251324397. Epub 2025 Feb 25 PubMed.PAPER Su B, He Z, Mao L, Huang X
The causal role of lipids in dementia: A Mendelian randomization study.
J Alzheimers Dis Rep. 2025;9:25424823241312106. Epub 2025 Jan 13 PubMed.PAPER Valle-Medina A, Calzada-Mendoza CC, Ocharan-Hernández ME, Jiménez-Zamarripa CA, Juárez-Cedillo T
Heat shock protein 70 in Alzheimer's disease and other dementias: A possible alternative therapeutic.
J Alzheimers Dis Rep. 2025;9:25424823241307021. Epub 2025 Jan 13 PubMed.PAPER Patil N, Patil K, Jain M, Mohammed A, Yadav A, Dhanda PS, Kole C, Dave K, Kaushik P, Azhar Abdul Razab MK, Hamzah Z, Nawi NM
A systematic study of molecular targets of cannabidiol in Alzheimer's disease.
J Alzheimers Dis Rep. 2024;8(1):1339-1360. Epub 2024 Oct 11 PubMed.PAPER Li T, Yi J, Hu X, Wu H, Wang K, Zhou B
Association between dementia, Alzheimer's disease, and liver cancer: A Mendelian randomization analysis.
J Alzheimers Dis Rep. 2024;8(1):1587-1595. Epub 2024 Nov 24 PubMed.PAPER Don Bosco RB, Selvan Christyraj JR, Yesudhason BV
Synergistic activity of nootropic herbs as potent therapeutics for Alzheimer's disease: A cheminformatics, pharmacokinetics, and system pharmacology approach.
J Alzheimers Dis Rep. 2024;8(1):1745-1762. Epub 2024 Dec 23 PubMed.Current Filters
- Date Range : Mar 2025 to Mar 2025 x